Gaviria BME, Gómez VLM

Idioma: Español
Referencias bibliográficas: 50
Paginas: 79-88
Archivo PDF: 369.19 Kb.

RESUMEN

El síndrome de uña frágil es el segundo motivo de consulta más frecuente por enfermedades de la uña en dermatología. Se caracteriza por onicorrexis, onicosquisis y ruptura de la lámina ungular como consecuencia de enfermedades sistémicas o dermatológicas, de deficiencias nutricionales, factores ambientales y asociados a la ocupación que puedan afectar la producción o el daño de las uñas ya queratinizadas. Este síndrome puede presentarse también de manera idiopática y aparte de sus resultados cosméticos desagradables, tiene un impacto psicosocial, pues la sintomatología afecta las actividades de la vida cotidiana. El tratamiento no es fácil, debe identificarse la causa desencadenante y aplicar medidas de control ambiental. Actualmente hay en el mercado una gran variedad de endurecedores y pueden administrarse suplementos vitamínicos como la biotina, oligoelementos y aminoácidos.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Shemer A, Daniel CR III. Common nail disorders. Clin Dermatol. 2013; 31 (5): 578-586.

2. Iorizzo M, Pazzaglia M, Piraccini B, Tullo S, Tosti A. Brittle nails. J Cosmet Dermatol. 2004; 3: 138-144.

3. van de Kerkhof PCM, Pasch MC, Scher RK, Kerscher M, Gieler U, Haneke E, et al. Brittle nail syndrome: a pathogenesis-based approach with a proposed grading system. J Am Acad Dermatol. 2005; 53: 644-651.

4. Baran R, Schoon D. Nail fragility syndrome and its treatment. J Cosmet Dermatol. 2004; 3 (3): 131-137.

5. Stern DK, Diamantis S, Smith E, Wei H, Gordon M, Muigai W et al. Water content and other aspects of brittle versus normal fingernails. J Am Acad Dermatol. 2007; 57 (1): 31-36.

6. Kechijian P. Brittle fingernails. Dermatol Clin. 1985; 3: 421-429.

7. Lubach D, Cohrs W, Wurzinger R. Incidence of brittle nails. Dermatológica. 1986; 172 (3): 144-147.

8. Colombo VE, Gerber F, Bronhofer M, Floersheim GL. Treatment of brittle fingernails and onychoschizia with biotin: scanning electron microscopy. J Am Acad Dermatol. 1990; 23 (6 Pt 1): 1127-1132.

9. Gequelim GC, Kubota CY, Sanches S, Dranka D, Mejia MM, Sumiya FM et al. Perception of brittle nails in dermatologic patients: a cross-sectional study. An Bras Dermatol. 2013; 88 (6): 1022-1025.

10. Shelley WB, Shelley ED. Onychoschizia: scanning electron microscopy. J Am Acad Dermatol. 1984; 10: 623-627.

11. Uyttendaele H, Geyer A, Scher RK. Brittle nails: pathogenesis and treatment. J Drugs Dermatol. 2003; 2: 48-49.

12. de Berker D. The physical basis of cosmetic defects of the nail plate. J Cosm Dermatol. 2002; 1: 35-42.

13. Rowland-Payne CM. Brittle nails, fragile nails. J Cosmet Dermatol. 2004; 3 (3): 119-121.

14. Helmdach M, Thielitz A, Röpke EM, Gollnick H. Age and sex variation in lipid composition of human fingernail plates. Skin Pharmacol Appl Skin Physiol. 2000; 13: 111-119.

15. Lubach D, Beckers P. Wet working conditions increase brittleness of nails, but do not cause it. Dermatology. 1992; 185 (2): 120-213.

16. Dimitris R, Ralph D. Management of simple brittle nails. Dermatol Ther. 2012; 25 (6): 569-573.

17. Singh G, Haneef NS, Uday A. Nail changes and disorders among the elderly. Indian J Dermatol Venereol Leprol. 2005; 71 (6): 386-392.

18. Dogra A, Arora AK. Nail psoriasis: the journey so far. Indian J Dermatol. 2014; 59 (4): 319-333.

19. Schons KR, Knob CF, Murussi N, Beber AA, Neumaier W, Monticielo OA. Nail psoriasis: a review of the literature. An Bras Dermatol. 2014; 89 (2): 312-317.

20. Rich P, Scher RK. Nail psoriasis severity index: a useful tool for evaluation of nail psoriasis. J Am Acad Dermatol. 2003; 49: 206-212.

21. Tosti A, Piraccini BM. Dermatological diseases. In: Nails: diagnosis, therapy, and surgery. Scher RK, Daniel CR III (Ed). Elsevier Saunders; 2005.

22. Goettmann S, Zaraa I, Moulonguet I. Nail lichen planus: epidemiological, clinical, pathological, therapeutic and prognosis study of 67 cases. J Eur Acad Dermatol Venereol. 2012; 26 (10): 1304-1309.

23. Piraccini BM, Saccani E, Starace M, Balestri R, Tosti A. Nail lichen planus: response to treatment and long term follow-up. Eur J Dermatol. 2010; 20: 489-496.

24. de Berker D, Higgins C, Jahoda C, Christiano A. Biology of hair and nails. In: Dermatology. Bolognia J, Jorizo J, Schaffer J (Ed). Elsevier Saunders; 2012.

25. Salem A, Gamil H, Hamed M, Galal S. Nail changes in patients with liver disease. J Eur Acad Dermatol Venereol. 2010; 24 (6): 649-654.

26. Duarte AF, Correia O, Baran R. Nail plate cohesion seems to be water independent. Int J Dermatol. 2009; 48: 193-195.

27. Rycroft RJG, Baran R. Occupational abnormalities and contact dermatitis. In: Baran R, Dawber RPR, editors. Diseases of the nails and their management. 3rd ed. Oxford: Blackwell; 2001. pp. 1-79, 205-265, 279.

28. Garson JC, Baltenneck F, Leroy F, Riele C, Muller M. Histological structure of human nails as studied by synchroton X-ray microdiffraction. Cell Mol Biol. 2000; 46: 1025-1034.

29. Wallis MS, Bowen WR, Guin JD. Pathogenesis of onychoschizia (lamellar dystrophy). J Am Acad Dermatol. 1991; 24: 44-48.

30. Geyer AS, Onumah N, Uyttendaele H, Scher RK. Modulation of linear nail growth to treat diseases of the nail. J Am Acad Dermatol. 2004; 50: 229-234.

31. Draelos ZD. Understanding and treating brittle nails. Cosmet Dermatol. 2009; 22: 598-599.

32. Uyttendaele H, Geyer A, Scher RK. Brittle nails: pathogenesis and treatment. J Drugs Dermatol. 2003; 2 (1): 48-49.

33. Haneke E. Onychocomeceuticals. J Cosmet Dermatol. 2006; 5: 95-100.

34. Iorizzo M, Piraccini BM, Tosti A. Nail cosmetics in nail disorders. J Cosmet Dermatol. 2007; 1: 53-58.

35. Baran R, Andre J. Side effects of nail cosmetics. J Cosmet Dermatol. 2005; 4: 204-209.

36. Dahdah MJ, Scher R. Nail diseases related to nail cosmetics. Dermatol Clin. 2006; 24: 233-239.

37. Baran R. Hydroxypropyl chitosan accelerates nail growth in healthy fingernails and in mycotic toenails. Buenos Aires: Poster 21st World Congress of Dermatology; 2007.

38. Cantoresi F, Caserini M, Bidoli A, Maggio F, Marino R, Carnevale C et al. Randomized controlled trial of a water-soluble nail lacquer based on hydroxypropyl-chitosan (hPCh), in the management of nail psoriasis. Clin Cosmet Investig Dermatol. 2014; 7: 185-190.

39. Monti D, Saccomani L, Chetoni P, Burgalassi S, Saettone MF, Mailland F. In vitro transungual permeation of ciclopirox from a hydroxypropyl chitosan-based, water soluble nail lacquer. Drug Dev Ind Pharm. 2005; 31: 11-17.

40. Sparavigna A, Caserini M, Tenconi B, De Ponti I, Palmieri R. effects of a novel nail lacquer based on hydroxypropyl-chitosan (HPCH) in subjects with fingernail onychoschizia. J Dermatolog Clin Res. 2004; 2 (2): 1013-1017.

41. Sparavigna A, Setaro M, Genet M, Frisenda L. Equisetum arvense in a new transungueal technology improves nail structure and appearance. Journal of Plastic Dermatology. 2006; 2 (1): 31-38.

42. Holzhuter G, Narayanan K, Gerber T. Structure of silica in Equisetum arvense. Anal Bioanal Chem. 2003; 376: 512-517.

43. Parcell S. Sulfur in human nutrition an application in medicine. Altern Med Rev. 2002; 7: 22-44.

44. Sparavigna A, Setaro M, Frisenda L. Physical and microbiological properties of a new nail protective medical device. J Cosmet Dermatol. 2008; 4: 5-12.

45. Sparavigna A, Setaro M, Frisenda L. Physical and microbiological properties of a new nail protective medical device. Journal of Plastic Dermatology. 2008; 4: 5-12.

46. Hochman LG, Scher RK, Meyerson MS. Brittle nails: response to daily biotin supplementation. Cutis. 1993; 51: 303-305.

47. Scheinfeld N, Dahdah MJ, Scher R. Vitamins and minerals: their role in nail health and disease. J Drugs Dermatol. 2007; 6 (8): 782-787.

48. Iorizzo M. Tips to treat the 5 most common nail disorders: brittle nails, onycholysis, paronychia, psoriasis, onychomycosis. Dermatol Clin. 2015; 33 (2): 175-183.

49. Scheinfeld N, Dahdah MJ, Scher RK. Vitamins and minerals: their role in nail health and disease. J Drugs Dermatol. 2007; 6: 782-786.

50. Cashman MW, Sloan SB. Nutrition and nail disease. Clin Dermatol. 2010; 28 (4): 420-425.